share_log

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $14

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $14

Craig-Hallum维持对Ironwood Pharmicals的买入,将目标股价下调至14美元
Benzinga ·  05/10 12:26

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy and lowers the price target from $18 to $14.

Craig-Hallum分析师蔡斯·尼克博克维持艾恩伍德制药公司(纳斯达克股票代码:IRWD)的买入并将目标股价从18美元下调至14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发